Treatment of Trichomoniasis in Men
Men with trichomoniasis should be treated with oral metronidazole 2 g as a single dose, which remains the preferred first-line regimen with cure rates of approximately 90-95% 1, 2, 3.
Primary Treatment Regimen
The recommended approach is straightforward:
- Metronidazole 2 g orally as a single dose (preferred)
- Alternative: Metronidazole 500 mg orally twice daily for 7 days 1, 2
The single-dose regimen is preferred because it ensures compliance through directly observed therapy and eliminates adherence concerns with multi-day regimens. Both regimens achieve similar cure rates when partner treatment is ensured 2.
Key Clinical Considerations
Topical therapy is ineffective. Metronidazole gel achieves cure rates <50% because it cannot reach therapeutic levels in the male urethra or perivaginal glands 1. Only oral metronidazole should be used.
Most infected men are asymptomatic, though some present with nongonococcal urethritis (NGU) 2. The absence of symptoms does not preclude treatment—men serve as important vectors for transmission to female partners.
Treatment Failure Protocol
If initial treatment fails, follow this escalation algorithm:
- First failure: Re-treat with metronidazole 500 mg twice daily for 7 days 1, 2, 1
- Second failure: Metronidazole 2 g once daily for 3-5 days 1, 2, 1
- Persistent failure: Consult infectious disease specialist and obtain susceptibility testing through CDC (770-488-4115) 1
Treatment failures typically result from reinfection rather than true resistance—metronidazole resistance remains low at 4.3% 3. Most resistant strains respond to higher doses 1, 2.
Partner Management and Follow-Up
All sexual partners must be treated concurrently to prevent reinfection 1, 2, 1. Instruct patients to abstain from sexual intercourse until both they and their partners complete therapy and are asymptomatic.
No follow-up is needed for men who become asymptomatic after treatment or who were initially asymptomatic 1, 2, 1.
Special Populations
HIV-infected men receive identical treatment regimens as HIV-negative men 1, 2, 1.
Metronidazole allergy: No effective alternatives exist. Patients with immediate-type hypersensitivity can undergo desensitization 1, 2. Topical non-nitroimidazole agents have cure rates <50% and are not recommended 1.
Emerging Options
Secnidazole, a newer 5-nitroimidazole with longer half-life and favorable pharmacokinetics, shows promise with a 92.2% cure rate in women 4, 5. However, the 2-g single-dose metronidazole remains the established standard for men based on decades of clinical evidence 3.
Common Pitfalls to Avoid
- Do not use metronidazole gel—it is FDA-approved only for bacterial vaginosis and fails in trichomoniasis
- Do not skip partner treatment—this is the primary cause of apparent treatment failure
- Do not assume asymptomatic men don't need treatment—they remain infectious and can develop complications including prostatitis and reduced fertility 6